Moreover, BC HER2-positive status was strongly associated with prolonged OS, while the presence of extracranial metastases at BM diagnosis and symptomatic BM were correlated with both decreased OS and decreased intracranial PFS. This evidence concerns the gene ERBB2 and breast cancer.